Cargando…

Seroconversion for cytomegalovirus infection in a cohort of pregnant women in Québec, 2010–2013

Cytomegalovirus (CMV) is the leading cause of congenital infection and non-genetic sensorineural hearing loss in children. There are no recent data on the incidence of CMV infection during pregnancy in Canada. This present study was undertaken to determine the seroprevalence of CMV IgG antibodies an...

Descripción completa

Detalles Bibliográficos
Autores principales: LAMARRE, V., GILBERT, N. L., ROUSSEAU, C., GYORKOS, T. W., FRASER, W. D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855989/
https://www.ncbi.nlm.nih.gov/pubmed/26686548
http://dx.doi.org/10.1017/S0950268815003167
_version_ 1782430446363082752
author LAMARRE, V.
GILBERT, N. L.
ROUSSEAU, C.
GYORKOS, T. W.
FRASER, W. D.
author_facet LAMARRE, V.
GILBERT, N. L.
ROUSSEAU, C.
GYORKOS, T. W.
FRASER, W. D.
author_sort LAMARRE, V.
collection PubMed
description Cytomegalovirus (CMV) is the leading cause of congenital infection and non-genetic sensorineural hearing loss in children. There are no recent data on the incidence of CMV infection during pregnancy in Canada. This present study was undertaken to determine the seroprevalence of CMV IgG antibodies and the rate of seroconversion in a cohort of pregnant women in the province of Québec, Canada. We used serum samples and questionnaire data collected as part of the 3D Pregnancy and Birth Cohort Study (2010–2013) conducted in Québec, Canada. CMV IgG antibodies were determined in serum samples collected at the first and third trimesters. Associations between independent variables and seroprevalence were assessed using logistic regression, and associations with seroconversions, by Poisson regression. Of 1938 pregnant women tested, 40·4% were seropositive for CMV at baseline. Previous CMV infection was associated with: working as a daycare educator, lower education, lower income, having had children, first language other than French or English, and being born outside Canada or the United States. Of the 1122 initially seronegative women, 24 (2·1%) seroconverted between their first and third trimesters. The seroconversion rate was 1·4 [95% confidence interval (CI) 0·9–2·1]/10 000 person-days at risk or 3·9 (95% CI 2·5–5·9)/100 pregnancies (assuming a 280-day gestation). The high proportion of pregnant women susceptible to CMV infection (nearly 60%) and the subsequent rate of seroconversion are of concern.
format Online
Article
Text
id pubmed-4855989
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-48559892016-05-11 Seroconversion for cytomegalovirus infection in a cohort of pregnant women in Québec, 2010–2013 LAMARRE, V. GILBERT, N. L. ROUSSEAU, C. GYORKOS, T. W. FRASER, W. D. Epidemiol Infect Original Papers Cytomegalovirus (CMV) is the leading cause of congenital infection and non-genetic sensorineural hearing loss in children. There are no recent data on the incidence of CMV infection during pregnancy in Canada. This present study was undertaken to determine the seroprevalence of CMV IgG antibodies and the rate of seroconversion in a cohort of pregnant women in the province of Québec, Canada. We used serum samples and questionnaire data collected as part of the 3D Pregnancy and Birth Cohort Study (2010–2013) conducted in Québec, Canada. CMV IgG antibodies were determined in serum samples collected at the first and third trimesters. Associations between independent variables and seroprevalence were assessed using logistic regression, and associations with seroconversions, by Poisson regression. Of 1938 pregnant women tested, 40·4% were seropositive for CMV at baseline. Previous CMV infection was associated with: working as a daycare educator, lower education, lower income, having had children, first language other than French or English, and being born outside Canada or the United States. Of the 1122 initially seronegative women, 24 (2·1%) seroconverted between their first and third trimesters. The seroconversion rate was 1·4 [95% confidence interval (CI) 0·9–2·1]/10 000 person-days at risk or 3·9 (95% CI 2·5–5·9)/100 pregnancies (assuming a 280-day gestation). The high proportion of pregnant women susceptible to CMV infection (nearly 60%) and the subsequent rate of seroconversion are of concern. Cambridge University Press 2016-06 2015-12-21 /pmc/articles/PMC4855989/ /pubmed/26686548 http://dx.doi.org/10.1017/S0950268815003167 Text en © Cambridge University Press 2015 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Papers
LAMARRE, V.
GILBERT, N. L.
ROUSSEAU, C.
GYORKOS, T. W.
FRASER, W. D.
Seroconversion for cytomegalovirus infection in a cohort of pregnant women in Québec, 2010–2013
title Seroconversion for cytomegalovirus infection in a cohort of pregnant women in Québec, 2010–2013
title_full Seroconversion for cytomegalovirus infection in a cohort of pregnant women in Québec, 2010–2013
title_fullStr Seroconversion for cytomegalovirus infection in a cohort of pregnant women in Québec, 2010–2013
title_full_unstemmed Seroconversion for cytomegalovirus infection in a cohort of pregnant women in Québec, 2010–2013
title_short Seroconversion for cytomegalovirus infection in a cohort of pregnant women in Québec, 2010–2013
title_sort seroconversion for cytomegalovirus infection in a cohort of pregnant women in québec, 2010–2013
topic Original Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855989/
https://www.ncbi.nlm.nih.gov/pubmed/26686548
http://dx.doi.org/10.1017/S0950268815003167
work_keys_str_mv AT lamarrev seroconversionforcytomegalovirusinfectioninacohortofpregnantwomeninquebec20102013
AT gilbertnl seroconversionforcytomegalovirusinfectioninacohortofpregnantwomeninquebec20102013
AT rousseauc seroconversionforcytomegalovirusinfectioninacohortofpregnantwomeninquebec20102013
AT gyorkostw seroconversionforcytomegalovirusinfectioninacohortofpregnantwomeninquebec20102013
AT fraserwd seroconversionforcytomegalovirusinfectioninacohortofpregnantwomeninquebec20102013